期刊文献+

丙戊酸钠对骨髓增生异常综合征细胞株MUTZ-1增殖和凋亡的影响 被引量:4

Effects of Sodium Valproate on Proliferation and Apoptosis of Human Myelodysplastic Syndromes Cell Line MUTZ-1
下载PDF
导出
摘要 背景与目的:骨髓增生异常综合征(myelodysplastic syndrome,MDS)是一类多能造血干细胞的克隆增殖性疾病,目前临床尚无明确有效的治疗方法。研究发现丙戊酸钠(sodium valproate,VPA)可通过诱导细胞周期阻滞和凋亡来抑制肿瘤细胞的增殖,本实验探讨VPA对MDS细胞MUTZ-1增殖的抑制作用及其作用机理。方法:采用四甲基偶氮唑蓝(MTT)比色法检测VPA对细胞增殖的抑制作用;采用光学显微镜和电子显微镜观察VPA作用后细胞形态的变化;应用流式细胞术(FCM)检测不同浓度药物作用后细胞凋亡的比例及细胞周期分布的变化;通过逆转录聚合酶链反应(RT-PCR)技术和Westernblot方法分别检测药物作用后p21WAF1(细胞周期依赖性激酶抑制因子)在mRNA和蛋白质水平表达量的改变。结果:VPA对MUTZ-1细胞的增殖抑制作用呈时间和浓度依赖性。经4mmol/LVPA处理MUTZ-1细胞72h后,细胞呈现典型的凋亡细胞的形态特征:光镜下可见凋亡细胞胞体固缩、核固缩、核碎裂及凋亡小体;透射电镜下可见凋亡细胞核染色质边集、胞浆浓缩、密度增加,胞浆内可见大小不规则的染色质团块。流式细胞术检测结果表明经1、2、4mmol/LVPA作用72h后,细胞的凋亡率由处理前的(0.99±0.35)%分别上升为(3.14±0.87)%、(14.90±1.04)%、(22.46±1.74)%,与对照组相比差异有统计学意义(P<0.05);G0/G1期细胞比例逐渐增多,S期细胞比例逐渐减低,细胞被阻滞在G0/G1期(P<0.05)。RT-PCR和Westernblot技术均发现VPA作用MUTZ-1细胞72h后,明显促进p21WAF1mRNA和p21WAF1蛋白的表达(P<0.05)。结论:VPA能够通过上调p21WAF1的表达,阻滞MUTZ-1细胞于G0/G1期,最终抑制肿瘤细胞的增殖并诱导其凋亡。 BACKGROUND & OBJECTIVE: Myelodysplastic syndromes (MDS) are heterogeneous disorders with the expansion of malignant clones. No satisfactory treatment for MDS is available. Sodium vaiproate (VPA) can inhibit the proliferation of tumor cells by inducing Go/G1 phase arrest and cell apoptosis. This study was to investigate the effects of VPA on the proliferation of MDS cell line MUTZ-1, and explore possible mechanisms. METHODS. MUTZ-1 cells were treated with VPA. Cell proliferation was determined by MTT assay. Cell morphology was observed under microscope and transmission electron microscope, Cell apoptosis and cell cycle were analyzed by flow cytometry (FCM). The expression of p21^WAF1 (cyclin-dependent kinase inhibitor) was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. RESULTS. VPA inhibited the proliferation of MUTZ-1 cells in concentration- and time-dependent manners, When treated with 4 mmol/L VPA for 72 h, typical apoptotic morphologic features appeared in MUTZ-1 cells, condensation of cells and nuclear chromatin, disintegration of nuclear chromatin, and apoptotic bodies were observed under microscope; aggregation and margination of apoptotic nuclear chromatin, cytoplasm condensation, and irregular chromatin masses were observed under transmission electron microscope. The apoptosis rate was significantly higher in the cells treated with 1, 2, and 4 mmol/L VPA for 72 h than in untreated cells [(3.14±0.87)%, (14.90±1.04)% and (22.46±1.74)% vs, (0.99±0.35)%, P〈0.05]. After treatment of VPA, cell cycle was arrested obviously at G0/G1 phase (P〈0.05); the mRNA and protein levels of p21^WAF1 were up-regulated in MUTZ-1 cells (P〈0.05). CONCLUSIONS. VPA could induce G0/G1 phase arrest, inhibit the proliferation and induce the apoptosis of MUTZ-1 cells in vitro. The mechanism may be associated with the upregulation of p21^WAF1.
出处 《癌症》 SCIE CAS CSCD 北大核心 2007年第12期1323-1329,共7页 Chinese Journal of Cancer
基金 国家自然科学基金资助项目(No.30070318)~~
关键词 丙戊酸钠 骨髓增生异常综合征 MUTZ-1细胞株 凋亡 增殖 Sodium valproate Myelodysplastic syndromes (MDS) MUTZ- 1 cell Apoptosis Proliferation
  • 相关文献

参考文献15

  • 1Minucci S, Nervi C, Lo Coco F, et al. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? [J ]. Oncogene, 2001,20(24) : 3110- 3115.
  • 2Weidle U H, Grossmann A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment [J]. Anticancer Res, 2000,20(3A) : 1471-1485.
  • 3Takai N, Desmond J C, Kumagai T, et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells [J]. Clin Cancer Res, 2004, 10(3): 1141-1149.
  • 4Li X N, Shu Q, Su J M, et al. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC [J]. Mol Cancer Ther, 2005,4 (12) : 1912-1922.
  • 5薛红漫,李文益,郭海霞,夏焱,陈琴,刘勇.丙戊酸诱导白血病细胞凋亡机理的实验研究[J].中华儿科杂志,2005,43(12):894-898. 被引量:12
  • 6Gurvich N, Tsygankova O M, Meinkoth J L, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation [J]. Cancer Res, 2004,64(3) : 1079-1086.
  • 7Tang R, Faussat A M, Majdak P, et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1 [J]. Leukemia, 2004, 18(7): 1246-1251.
  • 8薛萌,陈宝安,邵泽叶,高冲,王骏,程坚,丁家华,孙耘玉,高峰,马燕,赵刚.羟基喜树碱对人骨髓增生异常综合征MUTZ-1细胞体外作用的研究[J].现代医学,2006,34(3):141-144. 被引量:3
  • 9徐昕,陈宝安,邵泽叶,夏国华,丁家华,朱怀刚,高冲,孙耘玉,Dohner K,Donher H.维生素K_2对人骨髓增生异常综合征细胞株MUTZ-1增殖抑制作用的实验研究[J].东南大学学报(医学版),2006,25(2):98-101. 被引量:2
  • 10Steube K G, Gignac S M, Hu Z B, et al. In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1 [J]. Leuk Lymphomia, 1997,25(3- 4) : 345-363.

二级参考文献51

  • 1李新刚,陈燕,吴青,刘红利.曲古菌素A调节NB4细胞组蛋白乙酰化和p21^(WAF1/CIP1)表达[J].华中科技大学学报(医学版),2005,34(1):41-43. 被引量:3
  • 2邵泽叶,陈宝安,夏国华,丁家华,朱怀刚.维生素K_2对K562细胞生长抑制作用的实验研究[J].东南大学学报(医学版),2005,24(5):310-314. 被引量:5
  • 3Steube KG,Gignac SM,Hu ZB,et al.In vitro culture studies of childhood myelodysplastic syndrome:establishment of the cell line MUTZ-1.Leuk Lymphoma,1997 ; 25:345 - 363
  • 4Mitelman F.Guidelines for Cancer Cytogenetics,An international system for human cytogenetic nomenclature (ISCN).Basel:S karger,1995:1-114
  • 5Morrison LE,Legator MS.Evaluation of two-color ratio-coding in fluorescence in situ hybridization to chromosome targets.Cytometry,1997; 27:314-326
  • 6Tehinda J,Neumann TE,Volpert S,et al.Characterization of chromosomal rearrangements in hematological diseases using spectral karyotyping.Diagn Mol Pathol,2004; 13:190 - 195
  • 7Buchner T,Hiddemann W.Therapeutic strategies in acute myeloid leukemia.Internist (Berl).2002 ;43:1203 - 1204,1207 - 1211
  • 8Kraus J,Cohen M,Speicher MR.Multicolour FISH fine mapping unravels an insertion as a complex chromosomal rearrangement involving six breakpoints and a 5.89 Mb large deletion.J Med Genet,2003; 40:e60
  • 9Toyota M,Kopecky KJ,Toyota MO,et al.Methylation profiling in acute myeloid leukemia.Blood,2001;97:2823 -2829
  • 10Xu Y,Voelter-Mahlknecht S,Mahlknecht U.The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl,c-Myc and HDAC3 in chronic myeloid leukemia cell lines.Int J Mol Med,2005,15:169-172.

共引文献26

同被引文献33

  • 1李妍,邱录贵.丙戊酸治疗恶性血液病的研究进展[J].国外医学(输血及血液学分册),2005,28(5):445-448. 被引量:2
  • 2薛红漫,李文益,郭海霞,夏焱,陈琴,刘勇.丙戊酸诱导白血病细胞凋亡机理的实验研究[J].中华儿科杂志,2005,43(12):894-898. 被引量:12
  • 3郑美芳,陈秋生,陈钰.CAG预激方案治疗骨髓增生异常综合征RAEB-T的疗效观察[J].白血病.淋巴瘤,2006,15(2):133-134. 被引量:8
  • 4Kundgen A,Strupp C,Aivado M,et al.Treatment of myelodysplastic syndromes with valproic acid alone or incombination with all-trans retinoic acid [J]. Blood, 2004,104(5): 1266-1269.
  • 5Claus R, Lubbert M. Epigenetic targets in hematopoletic malignancies[J]. Oncogene, 2003,22(42): 6489-6496.
  • 6Gottlicher M.Valproic acid:an old drug newly discovered as inhibitor ofhistone deacetylase.Ann Hematol,2004,83 (Suppl1):S91-92.
  • 7Lin RJ,Nagy L,Inoue S,et al.Role of the histone deacetylase complex in acute promyelocytic leukemia[J].Nature,1998; 391:811-814.
  • 8Marmomtein R.Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases[J].Biochem Soc Trans,2004; 32:904-909.
  • 9Nakamura M,Saito H,Ebinuma H,et al.Reduction of telomerase activity in human liver cancer coils by a histone deacetylase inhibitor[J].J Cell Physiol,2007; 187:392-401.
  • 10Bali P,Pranpat M,Bradner J,et al.Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat short protein 90; a novel basis for antileukemia activity of histone deacetylase inhibitors[J].J Biol Chem,2005 ; 280:26729-26734.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部